CA Patent

CA3266935A1 — 2-substituted piperidine derivatives, preparation methods and medicinal uses thereof

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2024-03-14 · 2y expired

What this patent protects

Patent listed against iptacopan-hydrochloride.

Drugs covered by this patent

iptacopan-hydrochloride (IPTACOPAN HYDROCHLORIDE)

Patent Metadata

Patent number: CA3266935A1
Jurisdiction: CA
Classification: —
Expires: 2024-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.